Medical Press Releases

NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Has $7.8 Million in Financing for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression / PTSD

As a recognized leader in titanium supply and engineered metal solutions, Laube Technology is excited to connect with the innovators shaping the future of orthopedics.

$NRXP Closing $7.8 Million in Financing for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute Treatment Model and Leading Investigative Site

$NRXP NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP): Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties

NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties

Cadrenal Therapeutics, Inc. (Stock Symbol: CVKD) $CVKD Tecarfarin Anticoagulant Reduces Drug on Drug Interactions Which Pose a Major Issue with Warfarin. Successful Phase III Could Enhance Liquidity and Quickly Attract Large Institutional Investors.

$BEAT Clinical Endpoints Successfully Met in Pivotal Study, Plus FDA Clearance for At-Home, High-Fidelity Heart Monitoring System.

$NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties. NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)

$300 Million Set up in Milestones for $NRXP on Tiered Double-Digit Royalties

The Association for Hospitality in Healthcare (AHIH), a new professional association committed to the discovery, review, and dissemination of evidence-based information on how hospitality services can enhance the patient experience in the delivery of...

$BEAT Forms Strategic Collaboration with AccurKardia for Ambulatory ECG Recording and Analysis to Advance Cardiac Monitoring Care. HeartBeam, Inc. (Stock Symbol: BEAT)

NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties

NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Has $7.8 Million in Financing for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute as Treatment Model and Leading Investigative Site for Suicidal Depression / PTSD

As a recognized leader in titanium supply and engineered metal solutions, Laube Technology is excited to connect with the innovators shaping the future of orthopedics.

In the world of pharmaceutical development and analytical testing, the quality and reliability of reference standards are non-negotiable. This is particularly true when working with Dabigatran, a direct thrombin inhibitor widely used in anticoagulant

Iraq's premier pharmaceutical leader, Urok Pharma, secures exclusive international certifications, delivering unmatched quality and redefining healthcare innovation in the region and beyond.

Unraveling Mirtazapine Nitroso Impurity 2 and the Growing Concern Over Nitrosamine Contaminants in Pharmaceuticals

$NRXP Closing $7.8 Million in Financing for Clinic Acquisitions and Purchase of Kadima Neuropsychiatry Institute Treatment Model and Leading Investigative Site

$NRXP NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP): Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties

NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties

Cadrenal Therapeutics, Inc. (Stock Symbol: CVKD) $CVKD Tecarfarin Anticoagulant Reduces Drug on Drug Interactions Which Pose a Major Issue with Warfarin. Successful Phase III Could Enhance Liquidity and Quickly Attract Large Institutional Investors.

$BEAT Clinical Endpoints Successfully Met in Pivotal Study, Plus FDA Clearance for At-Home, High-Fidelity Heart Monitoring System.

$NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties. NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)

$300 Million Set up in Milestones for $NRXP on Tiered Double-Digit Royalties

The Association for Hospitality in Healthcare (AHIH), a new professional association committed to the discovery, review, and dissemination of evidence-based information on how hospitality services can enhance the patient experience in the delivery of...

$BEAT Forms Strategic Collaboration with AccurKardia for Ambulatory ECG Recording and Analysis to Advance Cardiac Monitoring Care. HeartBeam, Inc. (Stock Symbol: BEAT)

An Exposé On Vaccine Quality, Global Accreditation Failures, And The Standards That Betrayed Us

NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP) $NRXP Set Up for $300 Million in Milestones on Tiered Double-Digit Royalties

NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP): License and Distribution Terms Set for Lucrative Suicide Depression Treatment; $31 Price Target from Respected Investment Analyst D. Boral Capital

Premier Dental Implant Center Dentaluxe Unveils Cutting-Edge New Website to Enhance Patient Experience in Jacksonville, Florida

For the full article and more on how to file and how the process works, visit link at end.

$NRXP is Poised to Address the $3 Billion + Suicidal Depression Market in the US

Hyderabad, March 16: It is an undeniable fact that quackery exists in the state, but complete eradication is not immediately possible, said Professor Kodandaram, Chief Advisor to the Government. However, he expressed his readiness to regulate it.

Company Solidifies Commitment to World-Class Quality Standards Across Aerospace, Automotive, Medical, and Consumer Industries

The Spark Design Organization welcomes entries from around the world to compete for the coveted Platinum, Gold, Silver, Bronze Spark Awards. Judges choose professional and student winners from all design categories

The Indian Medical Association (IMA) Telangana State Committee has strongly urged political parties to immediately stop encouraging unqualified quack doctors for electoral benefits. In a statement, IMA Telangana President Dr.

$NRXP given a $31 Price Target from Respected Investment Analyst D. Boral Capital

Introducing It's My Life: My Personal Record of Everything Important A Practical and Essential Guide to Organizing Your Personal Information Sheena J.

Dr. Jim Longobardi is pleased to announce the release of his new book, Patience with Patients: Reviving Bedside Manner, a timely and thought-provoking examination of the critical role empathy plays in modern healthcare.

New Sunday Health Vienna, VA Office Offers Confidential, No-Cost Cognitive Screenings and Educational Resources About Modifiable Risk Factors for Dementia

$NRXP $31 Price Target from Respected Investment Analyst D. Boral Capital

$NRXP New Drug Application for Treatment of Suicidal Depression. Completion of NDA Filing Expected in First Quarter of 2025

NRx Pharmaceuticals, Inc.: Stock Symbol: NRXP IS Aiming to be the First FDA-Approved Medication to Treat Suicidal Depression